Healthy Adaptation to Pregnancy, Postpartum and Parenthood
HAP3
2 other identifiers
interventional
572
1 country
1
Brief Summary
Healthy Adaptation to Pregnancy, Postpartum and Parenthood (HAP3) The HAP3 study is evaluating a new digital support program for pregnant women and their partners. The program includes the HAP3 Family App, which provides information and practical tools on healthy eating, physical activity, sleep, emotional well-being, pregnancy and postpartum care, healthy weight management, parenting, and child development. Researchers want to find out whether the app is easy to use, acceptable to families, and practical to implement during pregnancy and after birth. The study will also explore whether using the app may help improve parents' mental well-being, healthy lifestyle habits, weight management, and early child development. Participants will be randomly assigned to one of two groups. One group will receive access to the full HAP3 Family App, personalized coaching by phone or video call, and supportive messages. The other group will receive usual care and use the app only to complete study questionnaires. The study will follow families from pregnancy until six months after birth. Participants will complete questionnaires about their health, well-being, and parenting experiences. Those using the full app will also be asked to complete brief in-app check-ins about mood, sleep, stress, and daily habits. The HAP3 intervention is not a medical treatment and involves minimal risk. Potential benefits include increased awareness of health behaviors, access to evidence-based information, and support during the transition to parenthood. The study is being conducted by researchers from KU Leuven (Belgium), Vrije Universiteit Amsterdam (Netherlands), and Technische Universität Dresden (Germany) as part of the European HAP3 project.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 10, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
CompletedFirst Posted
Study publicly available on registry
September 23, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2029
September 23, 2026
September 1, 2026
2.7 years
August 10, 2026
September 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Participant Recruitment Rate
Percentage of eligible participants who provide informed consent and are enrolled in the study.
At enrollment (enrollment can be at any gestational age)
Participant Retention Rate
Percentage of enrolled participants who complete the 6-month postpartum assessment.
From enrollment until 6 months postpartum.
HAP3 Family App Acceptability
Acceptability assessed using a study-specific questionnaire developed for the HAP3 feasibility study and informed by the Attitudes towards Psychological Online Interventions Questionnaire (APOI). The questionnaire evaluates participants' perceptions, satisfaction, and acceptance of the HAP3 Family App. Higher scores indicate greater acceptability of the intervention. The questionnaire is currently undergoing psychometric evaluation and has not yet been formally validated.
From enrollment until 6 months postpartum.
HAP3 Family App Usability
Usability measured using the mHealth App Usability Questionnaire (MAUQ). Scores range from 1 (Strongly agree) to 7 (Strongly disagree). A higher overall mean score (closer to 7.0) indicates a more favorable evaluation of the mobile health application's usability.
From enrollment until 6 months postpartum.
Motivation for Eating Behavior Change
Behavioural Change Towards Eating Behaviour (IBEB) questionnaire, a study-specific measure based on the Stages of Change framework. Higher scores indicate greater readiness and motivation to adopt healthy eating behaviors. A total score is calculated from the questionnaire items; score range will be determined following validation of the instrument.
Baseline, 32 weeks pregnancy, and 6 months postpartum.
Motivation for Mental Health Behavior Change
Evaluated using the University of Rhode Island Change Assessment (URICA) scale. The URICA is a 32-item questionnaire scored on a 5-point Likert scale (1 = Strongly Disagree, 5 = Strongly Agree). It measures four subscales representing stages of behavior change: Precontemplation, Contemplation, Action, and Maintenance. A composite Readiness to Change score is calculated using the formula: Contemplation + Action + Maintenance - Precontemplation. Composite scores typically range from a minimum of -2 to a maximum of 14. Higher composite scores indicate a greater readiness and overall motivation to change the target behavior.
Baseline, 32 weeks pregnancy, and 6 months postpartum.
Secondary Outcomes (15)
Edinburgh Postnatal Depression Scale (EPDS)
Baseline, 32 weeks pregnancy, 6 weeks postpartum, and 6 months postpartum.
6-item State-Trait Anxiety Inventory (STAI-6)
Baseline, 32 weeks pregnancy, 6 weeks postpartum, 3 months postpartum, and 6 months postpartum.
Depression Anxiety Stress Scales, Stress Subscale (DASS-21)
Baseline, 32 weeks pregnancy, 6 weeks postpartum, 3 months postpartum, and 6 months postpartum.
Pregnancy-related Anxiety Questionnaire-Revised 2 (PRAQ-R2)
32 weeks pregnancy.
Paternal Pregnancy-related Anxiety Scale (PPrAS)
32 weeks pregnancy.
- +10 more secondary outcomes
Other Outcomes (9)
Health, Lifestyle, and Parenting-Related Outcomes
Baseline, 32 weeks pregnancy, 6 weeks postpartum, 3 months postpartum, and 6 months postpartum, depending on the specific measure.
Sleep Quality
32 weeks pregnancy, 6 weeks postpartum, and 6 months postpartum.
Physical activity
Baseline, 32 weeks pregnancy, and 6 months postpartum
- +6 more other outcomes
Study Arms (2)
HAP3 Family App Intervention
EXPERIMENTALParticipants receive access to the full HAP3 Family App, including evidence-based modules on mental health, nutrition, physical activity, sleep, weight management, pregnancy and postpartum care, parenting, Ecological Momentary Assessments (EMA), personalized dashboard messages, and video/phone coaching in addition to usual care.
Usual Care plus Questionnaire-Only App
NO INTERVENTIONParticipants receive usual perinatal care and access to a restricted version of the app used only for study questionnaires. They do not receive intervention modules, EMA, personalized messages, or coaching.
Interventions
The HAP3 Family App is a multicomponent digital behavioral intervention designed specifically for pregnant women and their partners during pregnancy and the first six months postpartum. The intervention combines self-monitoring, self-management, evidence-based educational modules, Ecological Momentary Assessments (EMA), personalized dashboard messages, and structured video/telephone coaching. Content addresses multiple interconnected domains including mental well-being, healthy eating, physical activity, sleep, healthy weight management, pregnancy and postpartum care, parenting, and child development. Unlike interventions that focus on a single health outcome, the HAP3 intervention provides integrated support for both physical and mental health and actively involves partners. The intervention is delivered through a mobile application and supported by a dashboard that enables tailored feedback and coaching based on participant engagement and self-reported experiences.
Eligibility Criteria
You may qualify if:
- Pregnant person aged 18 years or older.
- Currently pregnant (participants may be recruited at any stage of pregnancy, -although recruitment before 16 weeks of pregnancy is preferred).
- Sufficient proficiency in Dutch, German, or English.
- Resident of Belgium, the Netherlands, or Germany.
- Able and willing to provide informed consent.
- Partners:
- Partner of an eligible pregnant participant.
- Aged 18 years or older.
- Sufficient proficiency in Dutch, German, or English.
- Resident of Belgium, the Netherlands, or Germany.
- Able and willing to provide informed consent.
You may not qualify if:
- Current suicidal ideation.
- Severe mental health disorder (e.g., bipolar disorder, schizophrenia, borderline personality disorder).
- Severely debilitating physical health condition that substantially affects daily functioning (e.g., advanced cardiovascular disease, advanced respiratory disease, or active cancer).
- History of or planned bariatric surgery during the study period.
- Failure or unwillingness to provide informed consent.
- Current participation or planned enrollment in another clinical trial that may conflict with this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- KU Leuvenlead
- VU University of Amsterdamcollaborator
- Technische Universität Dresdencollaborator
- University of Dublin, Trinity Collegecollaborator
- University of Aarhuscollaborator
Study Sites (1)
Vrouw en Kind
Leuven, 3000, Belgium
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. dr.
Study Record Dates
First Submitted
August 10, 2026
First Posted
September 23, 2026
Study Start
September 1, 2026
Primary Completion (Estimated)
May 1, 2029
Study Completion (Estimated)
May 1, 2029
Last Updated
September 23, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be made available to external third parties. Data processing and management are strictly restricted to consortium partners under a Joint Controllership Agreement and a Data Processing Agreement to ensure GDPR compliance and protect participant privacy.